TTrialPathMatch Me to Trials
← Back to trials
RecruitingDietary AssessmentDietary and Lifestyle Behaviour ChangeDietary Behavior

BRE-13: Mediterranean Diet

Eligible age

18–80 yrs

Accepts

Women

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Explore the effect of MedDiet vs. Usual Diet on circulating and breast tumor fatty acid profiles. The investigators aim to examine impact on tumor biology in newly diagnosed participants.

Sponsor: University of Illinois Chicago

You may qualify if…

  • ✓ 1. Age ≥ 18 years;
  • ✓ 2. Newly diagnosed stage I-III luminal breast cancer
  • ✓ 3. Planned surgical resection at UI Health
  • ✓ 4. Ability to speak, read, write, and understand English
  • ✓ 5. A Mediterranean Eating Pattern for Americans (MEPA-III) score \<13 indicating that they do not currently follow a MedDiet;
  • ✓ 6. ECOG performance status of 0 or 1.

You may not qualify if…

  • ✕ 1. Currently following a MedDiet, vegan diet, or dietary restrictions (e.g., religious, food intolerance/allergy) that preclude adoption of a MedDiet;
  • ✕ 2. Lack of access to a space to safely store and reheat foods items;
  • ✕ 3. Living in facility that provides meals;
  • ✕ 4. Chronic CKD stage 3+ or currently receiving dialysis treatment;
  • ✕ 5. History of GI surgery involving removal of part of the stomach or intestines;
  • ✕ 6. Type 1 or Type 2 diabetes;
  • ✕ 7. Autoimmune or Inflammatory disease or immunocompromised; and
  • ✕ 8. Cachexia.

Where it's recruiting

Illinois

Chicago

Source: ClinicalTrials.gov · NCT07869355 · last updated 2026-11-16

BRE-13: Mediterranean Diet · TrialPath